Search Results

541 results

  1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 50

    Reducing nicotine in Burley tobacco by combining low alkaloid varieties and agronomic practices

    FISHER A.M.; FISHER C.R.; JI H.
    University of Kentucky, Lexington, KY, U.S.A.
    The United States Food and Drug Administration (FDA) has requested comments on a possible nicotine standard of 0.3-0.5 mg/g in tobacco filler. There are currently no publicly available varieties that approach this level. The objective of this study was to ...
  2. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP Sustainability Forum

    Agro-Phyto Sustainability Forum

    WILDE L.(1); PRIBIC V.(2); EVANS W.(3); ROYO E.(4); BARGIACCHI E.(5); COLARD S.(6)
    (1) twentyfifty Ltd, Frome, U.K.; (2) JT International S.A., Geneva, Switzerland; (3) Imperial Tobacco Limited, Durban, South Africa; (4) Philip Morris International, Cape Town, South Africa; (5) Consortium INSTM, Firenze, Italy; (6) CORESTA, Paris, France
    In 2015, the United Nations published 17 sustainable development goals and their corresponding targets to be achieved by 2030. Like other sectors, the tobacco and alternative product sectors are likely to impact most of the goals. Consequently, it is ...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 49

    The CORESTA in vitro test battery for combustible tobacco products: update from the 2004 Rationale and Strategy Report

    LEE K.M.(1); JORDAN K.G.(2); WIECZOREK R.(3); MOENNIKES O.(4); CLEMENTS J.(5); CROOKS I.(6); HASHIZUME T.(7); MILLER J.(8); WEBER E.(9); YOSHINO K.(7)
    (1) Altria Client Services, Richmond, VA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.; (3) Imperial Brands, Reemtsma Cigarettenfabriken GmbH, Hamburg, Germany; (4) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (5) Covance Laboratories Ltd, Harrogate, U.K.; (6) British American Tobacco (Investments) Ltd, R&D, Southampton, U.K.; (7) Japan Tobacco Inc., Yokohama, Kanagawa, Japan; (8) JT International SA, Geneva, Switzerland; (9) Ökolab, Vienna, Austria
    In 2004, the CORESTA In Vitro Toxicity Task Force issued a rationale and strategy report, commonly known as “the CORESTA in vitro test battery guideline”. The goals of this guideline were to: 1) develop the rationale and strategy for conducting in vitro ...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 58

    A consortium approach for consumer-reported outcome measures to assess tobacco- and nicotine-containing products

    ACQUADRO C.(1) on behalf of the CORESTA CROM Task Force: AYALA-FIERRO F.(2); BLACK R.(3); CAHOURS X.(4); CHREA C.(5); CURTIN G.(6); GILES L.(7); McCAFFREY S.(3); PARK C.H.(8); PRASAD K.(9); SHERWOOD N.(10); SHIFFMAN S.(11); SMITH J.(6); SPIES E.(5)
    (1) Mapi Research Trust, Lyon, France; (2) ITG Brands, Greensboro, NC, U.S.A.; (3) Altria Client Services, Richmond, VA, U.S.A.; (4) SEITA - Imperial Brands, Paris, France; (5) Philip Morris Products S.A., Neûchatel, Switzerland; (6) RAIS, Winston-Salem, NC, U.S.A.; (7) JT Int'l SA, Genève, Switzerland; (8) KT&G Research Institute, Daejeon, Republic of Korea; (9) British American Tobacco, Southampton, U.K.; (10) Neil Sherwood Consulting, Commugny, Switzerland; (11) Pinney Associates, Pittsburgh, PA, U.S.A.
    In the tobacco space, consumer-reported outcome measures (CROM) are essential for understanding motivations, subjective effects, and behavior. Such measures have become particularly important with the advent of candidate modified risk tobacco products ...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 60

    Can we still observe a net health benefit due to the introduction of modified-risk tobacco products (MRTPs) should the illegal trade in counterfeit cigarettes increase? A model perspective.

    LARROQUE S.; CHARRIERE M.; MEGER M.
    JT International SA, Geneva, Switzerland
    Since 2012 and the publication of the MRTP guidance by the U.S. FDA encouraging the use of computational modelling, many robust dynamic models have been developed that are projecting net health benefits in the whole population after introduction of ...
  6. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 052

    Relationship of alkaloids, PON, TSNAs, nitrate and nitrite: a two-year field analysis

    WU YING; JI HUIHUA; JACK FISHER A.; FANNIN F.; CHATTOPADHYAY N.; BUSH L.
    University of Kentucky, Lexington, KY, USA
    Tobacco-specific nitrosamines (TSNAs) are a class of nitrosamines that are included in the FDA’s Harmful and Potentially Harmful Constituents (HPHC) list. Two of these, Nʹ-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) ...
  7. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 101

    Characterization of the bacterial community associated with smokeless tobacco reference products under different storage conditions

    LIU SHUANG; GREENHUT I.; MOE L.
    University of Kentucky, Lexington, KY, USA
    In this study we characterize the bacterial communities associated with smokeless tobacco reference products (STRP), including loose leaf chewing tobacco (3S1), moist snuff (3S3), American snus (1S5), and Swedish snus (1S4) during a 1-year storage period. ...